Myocardial Fibrosis clinical trials

Explore recruiting myocardial fibrosis clinical trials.

Recruiting myocardial fibrosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Myocardial Fibrosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effect of Vitamin D supplementation on MyocardIal Fibrosis in PaTients with Acute Myocarditis (EDIT-AM): a multicenter, open-label, randomized controlled trial

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Pilot Study on the Use of Gadopiclenol for Enhanced Cardiac MRI in Children with Congenital Heart Conditions: A self-controlled, non-randomised, open-label study to compare the image quality and diagnostic performance of gadopiclenol versus gadoterate meglumine

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Effect of antifibrotic therapy on regression of myocardial fibrosis after transcatheter aortic valve implantation (TAVI) in aortic stenosis patients with high fibrotic burden

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

The efficacy and safety of Metoprolol as add-on treatment to standard of care in preventing cardiomyopathy in patients with Duchenne Muscular Dystrophy aged 8-17 years. A randomized, double-blind, placebo controlled study

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Effect of Treatment with Finerenone on Cardio-Renal Target Organ Damage in Patients with Type 2 Diabetes – A Randomized Trial

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Effect of Dapagliflozin on myocardial and renal function following aortic valve stenosis intervention

Denmark

Phase II and Phase III (Integrated) EU CTIS Study details

Myocardial Fibrosis trials by city

Myocardial Fibrosis in Toronto Myocardial Fibrosis in Vancouver Myocardial Fibrosis in Montreal Myocardial Fibrosis in Calgary Myocardial Fibrosis in Edmonton Myocardial Fibrosis in Ottawa Myocardial Fibrosis in Winnipeg Myocardial Fibrosis in Quebec City Myocardial Fibrosis in Hamilton Myocardial Fibrosis in Kitchener Myocardial Fibrosis in London Myocardial Fibrosis in Halifax Myocardial Fibrosis in New York Myocardial Fibrosis in Los Angeles Myocardial Fibrosis in Chicago Myocardial Fibrosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease